Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Asthma and allergy

  • Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
    Nora Drick, Jan Fuge, Benjamin Seeliger, Milan Speth, Jens Vogel-Claussen, Tobias Welte, Hendrik Suhling
    ERJ Open Research Oct 2022, 8 (4) 00207-2022; DOI: 10.1183/23120541.00207-2022
  • Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
    Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic, Renaud Louis
    ERJ Open Research Oct 2022, 8 (4) 00273-2022; DOI: 10.1183/23120541.00273-2022
  • Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance
    Antoine Beurnier, Youri Yordanov, Agnès Dechartres, Aurélien Dinh, Erwan Debuc, François-Xavier Lescure, Patrick Jourdain, Luc Jaulmes, Marc Humbert
    ERJ Open Research Oct 2022, 8 (4) 00012-2022; DOI: 10.1183/23120541.00012-2022
  • Body mass index increase: a risk factor for forced expiratory volume in 1 s decline for overweight and obese adults with asthma
    Nicolás Bermúdez Barón, Hannu Kankaanranta, Linnea Hedman, Martin Andersson, Caroline Stridsman, Anne Lindberg, Eva Rönmark, Helena Backman
    ERJ Open Research Oct 2022, 8 (4) 00110-2022; DOI: 10.1183/23120541.00110-2022
  • It is time to end our love affair with short-acting β2-agonists in asthma
    Michael G. Crooks, Shoaib Faruqi
    ERJ Open Research Oct 2022, 8 (4) 00353-2022; DOI: 10.1183/23120541.00353-2022
  • Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register
    Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Håkansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg
    ERJ Open Research Oct 2022, 8 (4) 00238-2022; DOI: 10.1183/23120541.00238-2022
  • Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
    Johannes A. Kroes, Aruna T. Bansal, Emmanuelle Berret, Nils Christian, Andreas Kremer, Anna Alloni, Matteo Gabetta, Chris Marshall, Scott Wagers, Ratko Djukanovic, Celeste Porsbjerg, Dominique Hamerlijnck, Olivia Fulton, Anneke ten Brinke, Elisabeth H. Bel, Jacob K. Sont
    ERJ Open Research Oct 2022, 8 (4) 00168-2022; DOI: 10.1183/23120541.00168-2022
  • Major cardiovascular events in patients with severe COPD with and without asthma: a nationwide cohort study
    Barbara Bonnesen, Pradeesh Sivapalan, Anna Kjær Kristensen, Mats Christian Højbjerg Lassen, Kristoffer Grundtvig Skaarup, Ema Rastoder, Rikke Sørensen, Josefin Eklöf, Tor Biering-Sørensen, Jens-Ulrik Stæhr Jensen
    ERJ Open Research Jul 2022, 8 (3) 00200-2022; DOI: 10.1183/23120541.00200-2022
  • Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma
    Fatemeh Moheimani, Nafeesa Shahdab, Stephen Cummings, Philip M. Hansbro, Christopher Ward
    ERJ Open Research Jul 2022, 8 (3) 00314-2022; DOI: 10.1183/23120541.00314-2022
  • Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma
    Elisa Franceschi, Nora Drick, Jan Fuge, Tobias Welte, Hendrik Suhling
    ERJ Open Research Jul 2022, 8 (3) 00138-2022; DOI: 10.1183/23120541.00138-2022

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 26
  • Acute lung injury and critical care (49)
  • Asthma and allergy (252)
  • CF and non-CF bronchiectasis (148)
  • COPD and smoking (362)
  • Epidemiology, occupational and environmental lung disease (63)
  • Genetics (30)
  • Interstitial and orphan lung disease (191)
  • Lung biology and experimental studies (93)
  • Lung cancer (82)
  • Lung imaging (63)
  • Lung structure and function (120)
  • Mechanisms of lung disease (5)
  • Paediatric pulmonology (116)
  • Pulmonary pharmacology and therapeutics (146)
  • Pulmonary vascular disease (97)
  • Respiratory clinical practice (98)
  • Respiratory infections and tuberculosis (380)
  • Sleep medicine (63)
  • Most Read
  • Twitter
Loading
  • Outcomes of community-acquired pneumonia using the Pneumonia Severity Index versus the CURB-65 in routine practice of emergency departments
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
  • Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society